Moreover, DKN-01, an IgG4 monoclonal antibody targeting DKK1 has been demonstrated to have therapeutic benefits in gastroesophageal malignancies (Wall et al., 2020), indicating the potential of DKK1 in cancer therapy. The gene discussed is DKK1; the disease is cancer.